Investegate |Belluscura PLC Announcements | Belluscura PLC: Belluscura Expands its Patent Portfolio
Investegate announcements from Belluscura PLC, Belluscura Expands its Patent Portfolio
Stay updated with breaking news from Separation Design Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Belluscura PLC, Belluscura Expands its Patent Portfolio
Tel: +44 (0)20 7933 8780 or [email protected] Paul McManus / Sam Allen About Belluscura plc ( www.belluscura.com ) Belluscura is a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organisations. Background & history Belluscura was established in the UK in December 2015 with the object of c...
Portfolio Company Update Belluscura plc announced the receipt of 510(k) Clearance from the US Food and Drug Administration (the "FDA") for its X-PLO 2R™, Portable Oxygen Concentrator Tekcapital plc, (AIM: TEK), (OTCQB: TEKCF) the UK intellectual property investment group focused on creating valuable products from investing in university technology, announces that its portfolio company Belluscura plc has been granted 510(k) clearance and marketing authorisation by the U.S. Food and Drug Administration (FDA) for the X-PLO 2R POC portable oxygen concentrator (POC). B...